ArticlePediatric surgery international2026
Renal outcomes and compensatory hypertrophy in survivors of unilateral non-syndromic Wilms tumour: a single-centre cross-sectional study from a tertiary-care institution in India.
Article in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study evaluated renal outcomes and contralateral compensatory hypertrophy in Unilateral Wilms tumour survivors because of a solitary functioning kidney which is vulnerable to hyperfiltration injury.
methodsThis cross-sectional study (January 2005-May 2023) included children with non-syndromic unilateral Wilms tumour. Renal function was assessed using the modified Schwartz formula (eGFR), 99mTc-DTPA plasma clearance and urinary albumin/creatinine ratio(ACR). Blood pressure was evaluated by office measurement and 24-hour ambulatory blood pressure monitoring (ABPM). Compensatory hypertrophy was assessed by CT volumetric segmentation.
resultsA total of 117 children were included (median age 84 months, IQR 60-120; median follow-up 40.7 months, IQR 16.6-74.3). Reduced eGFR (< 90 ml/min/1.73 m²) was identified in 14 of 116 (12.1%), and reduced 99mTc-DTPA plasma clearance in 38 of 55 (69.1%). Microalbuminuria was identified in 7 of 56 (12.5%), ABPM-detected hypertension in 4 of 48 (8.3%), and compensatory hypertrophy in 36 of 48 (75.0%). Applying the composite definition (any of: low eGFR, low DTPA GFR, microalbuminuria or ABPM-detected hypertension), renal dysfunction was present in 53 of 117 patients (45.3%). In a analysis restricted to the 31 patients who completed all four investigations, renal dysfunction was present in 25 of 31 (80.6%).
conclusionIsotopic GFR revealed silent nephron injury despite compensatory hypertrophy, with nearly half showing renal dysfunction undetected by creatinine-based eGFR. Creatinine-based eGFR alone risks under-detecting renal dysfunction.
Indexed as
Identifiers
42573811What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.